13D/13G Filings - LIGAND PHARMACEUTICALS INC (LGND)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-10-08
09:17 am
Purchase
2020-09-30 13G Ligand Pharmaceuticals Incorporated
LGND
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 3,038,285
11.800%
767,074increase
(+33.77%)
Filing
History
2020-08-28
5:19 pm
Sale
2020-08-25 13D Viking Therapeutics, Inc.
VKTX
LIGAND PHARMACEUTICALS INC
LGND
7,339,383
9.900%
-218,700decrease
(-2.89%)
Filing
History
Goto Prev, 0, 1, 2